G-CSF-based stem cell therapy for the heart-unresolved issues part A: paracrine actions, mobilization, and delivery

Mazen Kurdi1, George W Booz

  • 1Department of Chemistry and Life Sciences, College of Sciences and Engineering, Holy Spirit University of Kaslik, Jounieh, Lebanon.

Insights

Granulocyte colony-stimulating factor (G-CSF) therapy shows promise for heart repair despite past trial failures. Recent science explains setbacks and guides future G-CSF applications for cardiac recovery.

Area of Science:

  • Cardiovascular Research
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Large clinical trials using G-CSF for myocardial infarction showed disappointing results.
  • Previous animal and small human studies suggested G-CSF's potential for cardiac repair.
  • Recent scientific advances offer new insights into G-CSF's mechanisms and therapeutic potential.

Purpose of the Study:

  • To explain the failure of previous large-scale G-CSF clinical trials.
  • To review recent advances in G-CSF's direct protective effects on cardiac cells.
  • To explore G-CSF's role in stem cell mobilization and cardiac delivery for heart repair.

Main Methods:

  • Review of recent basic science findings.
  • Analysis of G-CSF's direct actions on cardiomyocytes.
  • Examination of stem cell mobilization and homing mechanisms.
  • Evaluation of G-CSF-related therapies for injured hearts.

Main Results:

  • G-CSF has direct protective effects on cardiac cells.
  • Understanding G-CSF's mechanisms can explain prior clinical trial failures.
  • New strategies for G-CSF-based stem cell therapy are emerging.
  • Advances in stem cell mobilization and delivery are promising.

Conclusions:

  • G-CSF-based therapies for cardiac repair warrant further investigation.
  • Recent scientific discoveries provide a rationale for revitalizing G-CSF research.
  • Optimized G-CSF strategies could lead to effective clinical applications for heart disease.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...